Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models

Cancer cell vaccine-based immunotherapy has received increasing interest in many clinical trials involving patients with breast cancer. Combining with appropriate adjuvants can enhance the weak immunogenic properties of tumor cell lysates (TCL). In this study, diphtheria toxin (DT) and two tandem re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ze-Yu, Xing, Yun, Liu, Bin, Lu, Lei, Huang, Xiao, Ge, Chi-Yu, Yao, Wen-Jun, Xu, Mao-Lei, Gao, Zhen-Qiu, Cao, Rong-Yue, Wu, Jie, Li, Tai-Ming, Liu, Jing-Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777491/
https://www.ncbi.nlm.nih.gov/pubmed/22464650
http://dx.doi.org/10.5732/cjc.011.10384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777491/
https://www.ncbi.nlm.nih.gov/pubmed/22464650
http://dx.doi.org/10.5732/cjc.011.10384

Ejemplares similares